The wisdom trial is based on faulty reasoning and has major design and execution problems

Area of Science:

• Oncology
• Medical Research Methodology

Background:

• Breast cancer screening efficacy is a critical public health issue.
• The WISDOM trial aimed to address the ongoing debate surrounding screening effectiveness.

Purpose of the Study:

• To critically evaluate the design and execution plan of the WISDOM trial.
• To assess the scientific validity and assumptions underpinning the WISDOM trial's methodology.

Main Methods:

• Review and analysis of the rationale and reasoning behind the WISDOM trial.
• Examination of the published parameters and study design of the WISDOM trial.

Main Results:

• The WISDOM trial's design is based on flawed assumptions and a misunderstanding of breast cancer screening data.
• The study design ignores advancements in screening, possesses a questionable endpoint, and may lack statistical power.
• Insurance company involvement raises concerns about potential cost-reduction motives influencing the trial.

Conclusions:

• The premise of a "debate" on screening efficacy is manufactured and not scientifically supported.
• The WISDOM trial's findings may be misleading due to its flawed foundation and methodology.